Aabo-Rosendal ApS: Financial statements 2023
CVR: 37086029
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
Aabo-Rosendal ApS (CVR 37086029) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK 2,784,347 and a net result of DKK 1,134,946 compared with DKK 2,254,841 the year before. That is a decrease of 33.1% compared with the year before. Equity in the 2023 report amounted to DKK 1,227,501. The solvency ratio was 66.6%. The company had 2 employees in the financial year.
- Gross Profit
- DKK 2,784,347
- Profit/Loss
- DKK 1,134,946
- Equity
- DKK 1,227,501
- Total Assets
- DKK 1,843,878
- Employees
- 2
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | 2.8 mio. | 1.1 mio. | 1.2 mio. | 2 |
| 2022 | - | 4.2 mio. | 2.3 mio. | 2.3 mio. | 4 |
| 2021 | - | 3.5 mio. | 1.8 mio. | 1.8 mio. | 2 |
| 2020 | - | 2.1 mio. | 567 t. | 641 t. | 2 |
| 2019 | - | 1.9 mio. | 499 t. | 575 t. | 3 |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
Aabo-Rosendal ApS has published its annual report for 2022. Gross profit came to DKK 4,159,005, and the net result was DKK 2,254,841.
About Aabo-Rosendal ApS
Aabo-Rosendal ApS was a Danish company of the type Anpartsselskab based in København Ø, founded in 2015. The company has been dissolved on 13 June 2025. The company was registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The company was previously named Neurokirurgisk Smerteklinik ApS. The company has 2 employees (2024). In 2023, the company reported a gross profit of DKK 2,784,347 and a net result of DKK 1,134,946 compared with DKK 2,254,841 the year before. Equity in the 2023 report amounted to DKK 1,227,501.